US Patent Issued to Thomas Jefferson University on Nov. 18 for "P-ethoxy nucleic acids for IGF-1R inhibition" (Texas, New Jersey, Pennsylvania Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,199, issued on Nov. 18, was assigned to Thomas Jefferson University (Philadelphia).

"P-ethoxy nucleic acids for IGF-1R inhibition" was invented by Ana Ashizawa (Bellaire, Texas), Douglas Craig Hooper (Medford, N.J.) and David W. Andrews (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of treating cancer or an autoimmune disease comprising administering a liposome that comprises neutral phospholipids and a P-ethoxy oligonucleotide that targets a IGF-1R-encoding polynucleotide."

The patent was filed on Nov. 18, 2021, under Application No. 17/530,051.

*For further information, including images, charts and table...